M&A Deal Summary |
|
|---|---|
| Date | 2016-05-24 |
| Target | Remedica |
| Sector | Life Science |
| Buyer(s) | Ascendis Health |
| Deal Type | Add-on Acquisition |
| Deal Value | 260M EUR |
SEARCH BY
Try For Free 7-Day Free Trial
Ascendis Health is a health and care brands company operating in plant & animal and human health. Ascendis’ strategy is to create a synergistic group of health product brands that cover the value chain from imports of raw materials, manufacturing, brands and through to distribution to consumers via retail and direct selling channels. As one part of its growth strategy Ascendis also has a strong focus on acquisitive growth utilizing the private equity deal team of its controlling shareholder Coast2Coast.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector (Life Science) | 1 of 1 |
| Type (Add-on Acquisition) | 4 of 4 |
| Country (Cyprus) | 1 of 1 |
| Year (2016) | 2 of 2 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-05-24 |
Scitec Holding BV
Orlando, Florida, United States Scitec Nutrition is a producer and sells a wide variety of sports nutrition products. |
Buy | €170M |
